Takeda engaged in antitrust scheme to delay generic constipation drug: U.S. jury

“The verdict is the ​first time ‌a jury has found a pharmaceutical company liable in class-action litigation over what is called a "pay-for-delay" agreement with generic rivals.

Summary generated from the RSS feed of Japan Times Latest. All article rights belong to the original publisher. Click through to read the full piece on www.japantimes.co.jp.